Once a Silicon Valley darling, DNA testing company 23andMe has now gone into administration—leaving behind not just a troubled balance sheet, but a trove of highly sensitive personal data. Millions of customers entrusted the firm with their genetic information, family histories, and health predispositions. Now, the burning question: what happens to that data? The debate has ignited fears over data ownership, consent, and corporate accountability. In the UK, administrators are bound by GDPR,...
